Breaking News

Quintiles, TMAC Sign Commercial Capabilities Pact

By Kristin Brooks | January 7, 2014

Expands integrated commercialization programs for U.S. customers

Quintiles and The Medical Affairs Company (TMAC) have entered a collaboration expanding each company’s medical affairs-related offerings for customers in the U.S. Quintiles will add TMAC’s medical science liaison (MSL) capabilities to its field-based medical solutions, with the goal of providing additional expertise to engage and encourage increased knowledge of research, products and devices. The collaboration also allows TMAC to leverage Quintiles’ clinical educators to facilitate ongoing education of healthcare professionals, patients and caregivers.
 
“Today, more than ever before, biopharma companies looking to commercialize products in the U.S. are focused on demonstrating the value and benefits of their products to an increasingly diverse range of stakeholders,” said Daryl Gaugler, senior vice president, Commercial Solutions at Quintiles. “As this stakeholder landscape and its requirements continue to evolve, we are delighted to be working alongside a company like TMAC to offer the full spectrum of commercialization services, with an integrated approach to sales, medical science liaison, clinical education and market entry.”
 
“Requirements for medical affairs activities are expanding across the product life cycle,” said Evan Demestihas, M.D., chief executive officer, TMAC. “Working with companies like TMAC and Quintiles provides customers with benefits in terms of strategic oversight, speedy deployment and operational flexibility, while maintaining the discipline-specific and therapy area expertise that are essential to medical affairs teams. Through this collaboration, we believe Quintiles and TMAC will offer customers turn-key field commercialization capabilities that are unmatched in our industry.”
blog comments powered by Disqus
  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision